These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 8086447

  • 1. DNA unknotting activity (DNA topoisomerase II) isolated from a thermophilic archaebacterium Sulfolobus is inhibited by novobiocin. Partial purification, identification of the two subunits and characteristics of the enzyme.
    Assairi LM.
    Biochim Biophys Acta; 1994 Sep 13; 1219(1):107-14. PubMed ID: 8086447
    [Abstract] [Full Text] [Related]

  • 2. Reconstitution of DNA topoisomerase VI of the thermophilic archaeon Sulfolobus shibatae from subunits separately overexpressed in Escherichia coli.
    Buhler C, Gadelle D, Forterre P, Wang JC, Bergerat A.
    Nucleic Acids Res; 1998 Nov 15; 26(22):5157-62. PubMed ID: 9801313
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Purification of a DNA topoisomerase II from the hyperthermophilic archaeon Sulfolobus shibatae. A thermostable enzyme with both bacterial and eucaryal features.
    Bergerat A, Gadelle D, Forterre P.
    J Biol Chem; 1994 Nov 04; 269(44):27663-9. PubMed ID: 7961685
    [Abstract] [Full Text] [Related]

  • 5. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
    Kranz RG, Beckman DL, Foster-Hartnett D.
    FEMS Microbiol Lett; 1992 May 15; 72(1):25-32. PubMed ID: 1319375
    [Abstract] [Full Text] [Related]

  • 6. The interaction between coumarin drugs and DNA gyrase.
    Maxwell A.
    Mol Microbiol; 1993 Aug 15; 9(4):681-6. PubMed ID: 8231802
    [Abstract] [Full Text] [Related]

  • 7. Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme.
    Shaffer R, Traktman P.
    J Biol Chem; 1987 Jul 05; 262(19):9309-15. PubMed ID: 3036853
    [Abstract] [Full Text] [Related]

  • 8. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ, Corbett AH, Osheroff N.
    Biochemistry; 1993 Apr 13; 32(14):3638-43. PubMed ID: 8385484
    [Abstract] [Full Text] [Related]

  • 9. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
    Hooper DC, Wolfson JS, McHugh GL, Winters MB, Swartz MN.
    Antimicrob Agents Chemother; 1982 Oct 13; 22(4):662-71. PubMed ID: 6295263
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and coumermycin.
    Sekiguchi J, Stivers JT, Mildvan AS, Shuman S.
    J Biol Chem; 1996 Jan 26; 271(4):2313-22. PubMed ID: 8567695
    [Abstract] [Full Text] [Related]

  • 11. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.
    Marcu MG, Schulte TW, Neckers L.
    J Natl Cancer Inst; 2000 Feb 02; 92(3):242-8. PubMed ID: 10655441
    [Abstract] [Full Text] [Related]

  • 12. ATP-dependent DNA topoisomerase from the archaebacterium Sulfolobus acidocaldarius. Relaxation of supercoiled DNA at high temperature.
    Mirambeau G, Duguet M, Forterre P.
    J Mol Biol; 1984 Nov 05; 179(3):559-63. PubMed ID: 6096554
    [Abstract] [Full Text] [Related]

  • 13. Modulation of gyrase-mediated DNA cleavage and cell killing by ATP.
    Li TK, Liu LF.
    Antimicrob Agents Chemother; 1998 May 05; 42(5):1022-7. PubMed ID: 9593120
    [Abstract] [Full Text] [Related]

  • 14. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC, Shahied SI.
    Arch Biochem Biophys; 1995 Dec 01; 324(1):123-9. PubMed ID: 7503546
    [Abstract] [Full Text] [Related]

  • 15. Regenerating rat liver topoisomerase II: purification of the enzyme and catenation of DNA rings.
    Mirambeau G, Lavenot C, Duguet M.
    Adv Exp Med Biol; 1984 Dec 01; 179():423-33. PubMed ID: 6098161
    [No Abstract] [Full Text] [Related]

  • 16. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P, Nagaraja V.
    Mol Microbiol; 2005 Dec 01; 58(5):1392-405. PubMed ID: 16313624
    [Abstract] [Full Text] [Related]

  • 17. Yeast DNA topoisomerase II. An ATP-dependent type II topoisomerase that catalyzes the catenation, decatenation, unknotting, and relaxation of double-stranded DNA rings.
    Goto T, Wang JC.
    J Biol Chem; 1982 May 25; 257(10):5866-72. PubMed ID: 6279616
    [Abstract] [Full Text] [Related]

  • 18. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.
    Bellon S, Parsons JD, Wei Y, Hayakawa K, Swenson LL, Charifson PS, Lippke JA, Aldape R, Gross CH.
    Antimicrob Agents Chemother; 2004 May 25; 48(5):1856-64. PubMed ID: 15105144
    [Abstract] [Full Text] [Related]

  • 19. Effects of ATP and inhibitory factors on the activity of vaccinia virus type I topoisomerase.
    Foglesong PD, Bauer WR.
    J Virol; 1984 Jan 25; 49(1):1-8. PubMed ID: 6317884
    [Abstract] [Full Text] [Related]

  • 20. Studies on DNA polymerases and topoisomerases in archaebacteria.
    Forterre P, Elie C, Sioud M, Hamal A.
    Can J Microbiol; 1989 Jan 25; 35(1):228-33. PubMed ID: 2541877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.